Visceral adiposity as a target for the management of the metabolic syndrome
暂无分享,去创建一个
[1] T. Funahashi,et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study) , 2012, Annals of medicine.
[2] T. Funahashi,et al. 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. , 2010, Atherosclerosis.
[3] Lawrence Joseph,et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[4] T. Funahashi,et al. Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. , 2010, Journal of atherosclerosis and thrombosis.
[5] T. Funahashi,et al. Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. , 2010, Atherosclerosis.
[6] T. Funahashi,et al. One-Year Reductions in Body Weight and Blood Pressure, but Not in Visceral Fat Accumulation and Adiponectin, Improve Urinary Albumin-to-Creatinine Ratio in Middle-Aged Japanese Men , 2010, Diabetes Care.
[7] K. Petersen,et al. Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.
[8] S. Ho,et al. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies , 2010, European Journal of Epidemiology.
[9] Y. Matsuzawa. Establishment of a concept of visceral fat syndrome and discovery of adiponectin , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[10] Yoshiyu Takeda,et al. Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle‐aged Japanese , 2010, Obesity.
[11] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[12] T. Funahashi,et al. Changes in Serum Adiponectin Concentrations Correlate With Changes in BMI, Waist Circumference, and Estimated Visceral Fat Area in Middle-Aged General Population , 2009, Diabetes Care.
[13] R. Vasan,et al. Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot? , 2009, Diabetes Care.
[14] M. Roden,et al. Ectopic lipids and organ function , 2009, Current opinion in lipidology.
[15] Stefan Ma,et al. Rationale for redefining obesity in Asians. , 2009, Annals of the Academy of Medicine, Singapore.
[16] Y. Kokubo,et al. Impact of Metabolic Syndrome Components on the Incidence of Cardiovascular Disease in a General Urban Japanese Population: The Suita Study , 2008, Hypertension Research.
[17] Anoop Misra,et al. Obesity and the metabolic syndrome in developing countries. , 2008, The Journal of clinical endocrinology and metabolism.
[18] T. Funahashi,et al. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9 , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[19] M. Roden,et al. Ectopic fat and insulin resistance , 2008, Current diabetes reports.
[20] J. Després,et al. Abdominal obesity: the cholesterol of the 21st century? , 2008, The Canadian journal of cardiology.
[21] Philippe Pibarot,et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[22] V. Schrauwen-Hinderling,et al. Lipid accumulation in non-adipose tissue and lipotoxicity , 2008, Physiology & Behavior.
[23] S. Grundy. Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[24] 岡内 幸義. Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men , 2008 .
[25] P Zimmet,et al. Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[26] N. Wong,et al. The metabolic syndrome in East Asians. , 2007, Journal of the cardiometabolic syndrome.
[27] Udo Hoffmann,et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.
[28] Mahbubur Rahman,et al. Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study , 2007, Stroke.
[29] K. Yamagishi,et al. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women , 2007, Stroke.
[30] E. Oda. Minimum Waist and Visceral Fat Values for Identifying Japanese Americans at Risk for the Metabolic Syndrome , 2007, Diabetes Care.
[31] S. Kahn,et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans , 2007, Diabetologia.
[32] Victor M Montori,et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.
[33] T. Funahashi,et al. Metabolic syndrome: Clinical concept and molecular basis , 2007, Annals of medicine.
[34] I. Lemieux,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[35] Jiang He,et al. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. , 2006, The American journal of medicine.
[36] L. Kuller,et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study , 2006, International Journal of Obesity.
[37] J. Shaw,et al. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[38] B. Psaty,et al. Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, Ethnicity, and Coronary Artery Calcium , 2006, Circulation.
[39] J. Després,et al. Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.
[40] E. Ford,et al. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.
[41] S. Takagi,et al. Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese Men—The Tanno and Sobetsu Study , 2005, Hypertension Research.
[42] Makoto Nishida,et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.
[43] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[44] S. Klein,et al. The case of visceral fat: argument for the defense. , 2004, The Journal of clinical investigation.
[45] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[46] R. Unger. Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.
[47] Richard Hellman,et al. American College of Endocrinology position statement on the insulin resistance syndrome. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[48] Kazuhiko Ishikawa,et al. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[49] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[50] R. Ross,et al. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. , 2002, The Journal of clinical endocrinology and metabolism.
[51] M. Matsuda,et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.
[52] R. Bergman,et al. Extreme insulin resistance of the central adipose depot in vivo. , 2002, Diabetes.
[53] Robert Ross,et al. Abdominal adiposity and insulin resistance in obese men. , 2002, American journal of physiology. Endocrinology and metabolism.
[54] G. Lewis,et al. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. , 2001, Trends in cardiovascular medicine.
[55] T. Gill. Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: abdominal obesity. , 2001, Asia Pacific journal of clinical nutrition.
[56] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[57] H Scharfetter,et al. Assessing abdominal fatness with local bioimpedance analysis: basics and experimental findings , 2001, International Journal of Obesity.
[58] P. Wahl,et al. Type 2 diabetes and the metabolic syndrome in Japanese Americans. , 2000, Diabetes research and clinical practice.
[59] C. Bouchard,et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[60] B. Goodpaster,et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. , 2000, American journal of physiology. Endocrinology and metabolism.
[61] A. Kimmel,et al. On the Control of Lipolysis in Adipocytes , 1999, Annals of the New York Academy of Sciences.
[62] P. Wahl,et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. , 1999, Diabetes care.
[63] N. Schneiderman,et al. Ethnic variations in the pharmacological and nonpharmacological treatment of hypertension: biopsychosocial perspective. , 1999, Human biology.
[64] B. Balkau,et al. Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[65] J. M. Bloom. Pravastatin and coronary heart disease , 1999, The Lancet.
[66] S. Kihara,et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. , 1999, Internal medicine.
[67] R. Archbold,et al. Cholesterol lowering and coronary artery disease: mechanisms of risk reduction , 1998, Heart.
[68] G. Assmann,et al. Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM). , 1998, European heart journal.
[69] A. Bennett,et al. The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein , 1998, British Journal of Nutrition.
[70] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[71] S. Yamashita,et al. Enhanced expression of hepatic acyl‐coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation , 1998, Hepatology.
[72] Y. Matsuzawa,et al. Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.
[73] Y. Matsuzawa,et al. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. , 1997, Diabetes/metabolism reviews.
[74] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[75] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[76] W. Fujimoto. Overview of Non‐insulin‐dependent Diabetes Mellitus (NIDDM) in Different Population Groups , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[77] J. Lovejoy,et al. Abdominal fat distribution and metabolic risk factors: effects of race. , 1996, Metabolism: clinical and experimental.
[78] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[79] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[80] A. Boulton. Diabetic Medicine: The Southbound Migration Continues , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[81] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[82] P. Wahl,et al. Susceptibility to development of central adiposity among populations. , 1995, Obesity research.
[83] Y. Matsuzawa,et al. Pathophysiology and pathogenesis of visceral fat obesity. , 1995, Annals of the New York Academy of Sciences.
[84] P. Wahl,et al. Earlier Appearance of Impaired Insulin Secretion Than of Visceral Adiposity in the Pathogenesis of NIDDM: 5-Year Follow-up of Initially Nondiabetic Japanese-American Men , 1995, Diabetes Care.
[85] T Nakamura,et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.
[86] Y. Matsuzawa,et al. Pathophysiology and Pathogenesis of Visceral Fat Obesity , 1994, Diabetes research and clinical practice.
[87] Després Jp. Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.
[88] J. Albers,et al. Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.
[89] Ambady Ramachandran. Genetic epidemiology of NIDDM among Asian Indians. , 1992, Annals of medicine.
[90] L. Cominacini,et al. Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. , 1992, The American journal of cardiology.
[91] Y. Matsuzawa,et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. , 1991, International journal of obesity.
[92] K. Ensrud,et al. Racial and Ethnic Modifiers of the Salt-Blood Pressure Response , 1991, Hypertension.
[93] Y. Matsuzawa,et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. , 1990, Hypertension.
[94] A Tremblay,et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.
[95] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[96] N. Kaplan. The Deadly Quartet: Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension , 1989 .
[97] P. Wahl,et al. Plasma insulin levels in Japanese and Japanese-American men with type 2 diabetes may be related to the occurrence of cardiovascular disease. , 1989, Diabetes research and clinical practice.
[98] M. Austin. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. , 1989, American journal of epidemiology.
[99] P. Björntorp. Classification of obese patients and complications related to the distribution of surplus fat. , 1987, The American journal of clinical nutrition.
[100] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[101] H C Lukaski,et al. Validation of tetrapolar bioelectrical impedance method to assess human body composition. , 1986, Journal of applied physiology.
[102] H C Lukaski,et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.
[103] A. Kissebah,et al. Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .
[104] P. Björntorp,et al. Regional differences and effect of weight reduction on human fat cell metabolism , 1979, European journal of clinical investigation.
[105] W. Kannel,et al. RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY. , 1964, Annals of internal medicine.
[106] J. Vague. Sexual differentiation; Factor determining forms of obesity. , 1947 .
[107] L H Kuller,et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study , 2012, International Journal of Obesity.
[108] S. Kihara,et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. , 2008, Internal medicine.
[109] S. Dunbar,et al. Obesity and the Metabolic Syndrome , 2006 .
[110] P. Deedwania,et al. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics , 2006, Current atherosclerosis reports.
[111] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[112] R. Nesto. Beyond Low-Density Lipoprotein , 2005, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[113] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[114] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[115] S. Yamashita,et al. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. , 1996, Hypertension.
[116] J. Wright,et al. Essential hypertension: racial/ethnic differences in pathophysiology. , 1996, Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians.
[117] N. Kaplan. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. , 1989, Archives of internal medicine.
[118] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.
[119] Y. Matsuzawa,et al. A novel technique for the determination of body fat by computed tomography. , 1983, International journal of obesity.
[120] A. Kissebah,et al. Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.
[121] P. J. Randle. Fat Cells , 1972, Nature.